nodes	percent_of_prediction	percent_of_DWPC	metapath
Carmustine—Alkylating Activity—Dacarbazine—muscle cancer	0.57	1	CiPCiCtD
Carmustine—hematologic cancer—muscle cancer	0.359	1	CtDrD
Carmustine—CYP1A2—Dacarbazine—muscle cancer	0.0149	0.672	CbGbCtD
Carmustine—CYP1A2—Etoposide—muscle cancer	0.00728	0.329	CbGbCtD
Carmustine—GSR—embryo—muscle cancer	0.000446	0.185	CbGeAlD
Carmustine—GSR—renal system—muscle cancer	0.000338	0.14	CbGeAlD
Carmustine—GSR—cardiac atrium—muscle cancer	0.000302	0.126	CbGeAlD
Carmustine—GSR—tendon—muscle cancer	0.000264	0.109	CbGeAlD
Carmustine—GSR—bone marrow—muscle cancer	0.000255	0.106	CbGeAlD
Carmustine—GSR—vagina—muscle cancer	0.000245	0.102	CbGeAlD
Carmustine—GSR—head—muscle cancer	0.000226	0.0938	CbGeAlD
Carmustine—GSR—testis—muscle cancer	0.000218	0.0906	CbGeAlD
Carmustine—Abscess—Doxorubicin—muscle cancer	0.000126	0.00273	CcSEcCtD
Carmustine—Flushing—Dactinomycin—muscle cancer	0.000124	0.00268	CcSEcCtD
Carmustine—Injection site pain—Doxorubicin—muscle cancer	0.000122	0.00265	CcSEcCtD
Carmustine—Dysphagia—Etoposide—muscle cancer	0.000121	0.00261	CcSEcCtD
Carmustine—Hypoaesthesia—Vincristine—muscle cancer	0.000119	0.00257	CcSEcCtD
Carmustine—Hallucination—Vincristine—muscle cancer	0.000119	0.00257	CcSEcCtD
Carmustine—Alopecia—Dactinomycin—muscle cancer	0.000118	0.00255	CcSEcCtD
Carmustine—Connective tissue disorder—Vincristine—muscle cancer	0.000117	0.00254	CcSEcCtD
Carmustine—Erythema—Dactinomycin—muscle cancer	0.000116	0.00252	CcSEcCtD
Carmustine—Pulmonary embolism—Methotrexate—muscle cancer	0.000115	0.00249	CcSEcCtD
Carmustine—CYP1A2—renal system—muscle cancer	0.000115	0.0477	CbGeAlD
Carmustine—Pancytopenia—Etoposide—muscle cancer	0.000115	0.00248	CcSEcCtD
Carmustine—Extravasation—Doxorubicin—muscle cancer	0.000115	0.00248	CcSEcCtD
Carmustine—Neutropenia—Etoposide—muscle cancer	0.000113	0.00244	CcSEcCtD
Carmustine—Depressed level of consciousness—Methotrexate—muscle cancer	0.000111	0.00241	CcSEcCtD
Carmustine—Skin exfoliation—Methotrexate—muscle cancer	0.00011	0.00238	CcSEcCtD
Carmustine—Thinking abnormal—Doxorubicin—muscle cancer	0.000109	0.00236	CcSEcCtD
Carmustine—Pneumonia—Etoposide—muscle cancer	0.000108	0.00234	CcSEcCtD
Carmustine—Anaemia—Dactinomycin—muscle cancer	0.000108	0.00233	CcSEcCtD
Carmustine—Renal failure—Etoposide—muscle cancer	0.000106	0.00229	CcSEcCtD
Carmustine—Neuropathy peripheral—Etoposide—muscle cancer	0.000106	0.00228	CcSEcCtD
Carmustine—Alopecia—Vincristine—muscle cancer	0.000106	0.00228	CcSEcCtD
Carmustine—Coma—Methotrexate—muscle cancer	0.000105	0.00228	CcSEcCtD
Carmustine—Stomatitis—Etoposide—muscle cancer	0.000105	0.00227	CcSEcCtD
Carmustine—Mental disorder—Vincristine—muscle cancer	0.000105	0.00226	CcSEcCtD
Carmustine—Neoplasm—Methotrexate—muscle cancer	0.000104	0.00226	CcSEcCtD
Carmustine—Leukopenia—Dactinomycin—muscle cancer	0.000104	0.00225	CcSEcCtD
Carmustine—Gynaecomastia—Methotrexate—muscle cancer	0.000103	0.00223	CcSEcCtD
Carmustine—Gait disturbance—Doxorubicin—muscle cancer	0.000102	0.00221	CcSEcCtD
Carmustine—Coordination abnormal—Doxorubicin—muscle cancer	0.000102	0.0022	CcSEcCtD
Carmustine—Neck pain—Doxorubicin—muscle cancer	0.000101	0.00219	CcSEcCtD
Carmustine—Back pain—Vincristine—muscle cancer	0.000101	0.00217	CcSEcCtD
Carmustine—Sepsis—Methotrexate—muscle cancer	0.0001	0.00216	CcSEcCtD
Carmustine—Pulmonary embolism—Doxorubicin—muscle cancer	9.99e-05	0.00216	CcSEcCtD
Carmustine—Injection site reaction—Doxorubicin—muscle cancer	9.93e-05	0.00215	CcSEcCtD
Carmustine—Myalgia—Dactinomycin—muscle cancer	9.91e-05	0.00214	CcSEcCtD
Carmustine—Thrombophlebitis—Methotrexate—muscle cancer	9.68e-05	0.00209	CcSEcCtD
Carmustine—Diabetes mellitus—Methotrexate—muscle cancer	9.63e-05	0.00208	CcSEcCtD
Carmustine—Hypoaesthesia—Etoposide—muscle cancer	9.63e-05	0.00208	CcSEcCtD
Carmustine—Anaemia—Vincristine—muscle cancer	9.61e-05	0.00208	CcSEcCtD
Carmustine—Agitation—Vincristine—muscle cancer	9.55e-05	0.00207	CcSEcCtD
Carmustine—Skin exfoliation—Doxorubicin—muscle cancer	9.54e-05	0.00206	CcSEcCtD
Carmustine—Candida infection—Doxorubicin—muscle cancer	9.54e-05	0.00206	CcSEcCtD
Carmustine—Oedema—Dactinomycin—muscle cancer	9.5e-05	0.00205	CcSEcCtD
Carmustine—Infection—Dactinomycin—muscle cancer	9.44e-05	0.00204	CcSEcCtD
Carmustine—Neuropathy—Doxorubicin—muscle cancer	9.38e-05	0.00203	CcSEcCtD
Carmustine—Leukopenia—Vincristine—muscle cancer	9.31e-05	0.00201	CcSEcCtD
Carmustine—Thrombocytopenia—Dactinomycin—muscle cancer	9.3e-05	0.00201	CcSEcCtD
Carmustine—Coma—Doxorubicin—muscle cancer	9.13e-05	0.00197	CcSEcCtD
Carmustine—Anorexia—Dactinomycin—muscle cancer	9.05e-05	0.00196	CcSEcCtD
Carmustine—Eye disorder—Etoposide—muscle cancer	9.04e-05	0.00195	CcSEcCtD
Carmustine—Neoplasm—Doxorubicin—muscle cancer	9.03e-05	0.00195	CcSEcCtD
Carmustine—Convulsion—Vincristine—muscle cancer	9.01e-05	0.00195	CcSEcCtD
Carmustine—Flushing—Etoposide—muscle cancer	8.98e-05	0.00194	CcSEcCtD
Carmustine—Hypertension—Vincristine—muscle cancer	8.98e-05	0.00194	CcSEcCtD
Carmustine—Myalgia—Vincristine—muscle cancer	8.85e-05	0.00191	CcSEcCtD
Carmustine—Abnormal vision—Doxorubicin—muscle cancer	8.72e-05	0.00188	CcSEcCtD
Carmustine—Sepsis—Doxorubicin—muscle cancer	8.67e-05	0.00187	CcSEcCtD
Carmustine—Mental disability—Doxorubicin—muscle cancer	8.67e-05	0.00187	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Dactinomycin—muscle cancer	8.65e-05	0.00187	CcSEcCtD
Carmustine—Alopecia—Etoposide—muscle cancer	8.55e-05	0.00185	CcSEcCtD
Carmustine—Oedema—Vincristine—muscle cancer	8.49e-05	0.00183	CcSEcCtD
Carmustine—Infection—Vincristine—muscle cancer	8.43e-05	0.00182	CcSEcCtD
Carmustine—Phlebitis—Doxorubicin—muscle cancer	8.42e-05	0.00182	CcSEcCtD
Carmustine—Thrombophlebitis—Doxorubicin—muscle cancer	8.38e-05	0.00181	CcSEcCtD
Carmustine—Diabetes mellitus—Doxorubicin—muscle cancer	8.34e-05	0.0018	CcSEcCtD
Carmustine—Thrombocytopenia—Vincristine—muscle cancer	8.31e-05	0.0018	CcSEcCtD
Carmustine—Decreased appetite—Dactinomycin—muscle cancer	8.26e-05	0.00178	CcSEcCtD
Carmustine—Back pain—Etoposide—muscle cancer	8.15e-05	0.00176	CcSEcCtD
Carmustine—Pain—Dactinomycin—muscle cancer	8.12e-05	0.00176	CcSEcCtD
Carmustine—Anorexia—Vincristine—muscle cancer	8.09e-05	0.00175	CcSEcCtD
Carmustine—Eye pain—Doxorubicin—muscle cancer	8.03e-05	0.00174	CcSEcCtD
Carmustine—Hypotension—Vincristine—muscle cancer	7.93e-05	0.00171	CcSEcCtD
Carmustine—Ataxia—Methotrexate—muscle cancer	7.88e-05	0.0017	CcSEcCtD
Carmustine—Feeling abnormal—Dactinomycin—muscle cancer	7.83e-05	0.00169	CcSEcCtD
Carmustine—Anaemia—Etoposide—muscle cancer	7.78e-05	0.00168	CcSEcCtD
Carmustine—Gastrointestinal pain—Dactinomycin—muscle cancer	7.77e-05	0.00168	CcSEcCtD
Carmustine—Liver function test abnormal—Methotrexate—muscle cancer	7.73e-05	0.00167	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Vincristine—muscle cancer	7.73e-05	0.00167	CcSEcCtD
Carmustine—Insomnia—Vincristine—muscle cancer	7.67e-05	0.00166	CcSEcCtD
Carmustine—Paraesthesia—Vincristine—muscle cancer	7.62e-05	0.00165	CcSEcCtD
Carmustine—Leukopenia—Etoposide—muscle cancer	7.54e-05	0.00163	CcSEcCtD
Carmustine—Abdominal pain—Dactinomycin—muscle cancer	7.51e-05	0.00162	CcSEcCtD
Carmustine—Body temperature increased—Dactinomycin—muscle cancer	7.51e-05	0.00162	CcSEcCtD
Carmustine—Decreased appetite—Vincristine—muscle cancer	7.38e-05	0.00159	CcSEcCtD
Carmustine—Gastrointestinal disorder—Vincristine—muscle cancer	7.33e-05	0.00158	CcSEcCtD
Carmustine—Convulsion—Etoposide—muscle cancer	7.3e-05	0.00158	CcSEcCtD
Carmustine—Hyponatraemia—Doxorubicin—muscle cancer	7.28e-05	0.00157	CcSEcCtD
Carmustine—Hypertension—Etoposide—muscle cancer	7.27e-05	0.00157	CcSEcCtD
Carmustine—Constipation—Vincristine—muscle cancer	7.26e-05	0.00157	CcSEcCtD
Carmustine—Pain—Vincristine—muscle cancer	7.26e-05	0.00157	CcSEcCtD
Carmustine—Gastrointestinal haemorrhage—Doxorubicin—muscle cancer	7.25e-05	0.00157	CcSEcCtD
Carmustine—Diplopia—Doxorubicin—muscle cancer	7.25e-05	0.00157	CcSEcCtD
Carmustine—Chest pain—Etoposide—muscle cancer	7.17e-05	0.00155	CcSEcCtD
Carmustine—Face oedema—Doxorubicin—muscle cancer	7e-05	0.00151	CcSEcCtD
Carmustine—Hypersensitivity—Dactinomycin—muscle cancer	7e-05	0.00151	CcSEcCtD
Carmustine—Gastrointestinal pain—Vincristine—muscle cancer	6.94e-05	0.0015	CcSEcCtD
Carmustine—Confusional state—Etoposide—muscle cancer	6.93e-05	0.0015	CcSEcCtD
Carmustine—Pancytopenia—Methotrexate—muscle cancer	6.88e-05	0.00149	CcSEcCtD
Carmustine—Infection—Etoposide—muscle cancer	6.83e-05	0.00148	CcSEcCtD
Carmustine—Ataxia—Doxorubicin—muscle cancer	6.82e-05	0.00147	CcSEcCtD
Carmustine—Asthenia—Dactinomycin—muscle cancer	6.81e-05	0.00147	CcSEcCtD
Carmustine—Neutropenia—Methotrexate—muscle cancer	6.77e-05	0.00146	CcSEcCtD
Carmustine—Thrombocytopenia—Etoposide—muscle cancer	6.73e-05	0.00145	CcSEcCtD
Carmustine—Tachycardia—Etoposide—muscle cancer	6.71e-05	0.00145	CcSEcCtD
Carmustine—Abdominal pain—Vincristine—muscle cancer	6.71e-05	0.00145	CcSEcCtD
Carmustine—Body temperature increased—Vincristine—muscle cancer	6.71e-05	0.00145	CcSEcCtD
Carmustine—Liver function test abnormal—Doxorubicin—muscle cancer	6.7e-05	0.00145	CcSEcCtD
Carmustine—Hypokalaemia—Doxorubicin—muscle cancer	6.6e-05	0.00143	CcSEcCtD
Carmustine—Anorexia—Etoposide—muscle cancer	6.55e-05	0.00142	CcSEcCtD
Carmustine—Diarrhoea—Dactinomycin—muscle cancer	6.5e-05	0.0014	CcSEcCtD
Carmustine—Pneumonia—Methotrexate—muscle cancer	6.49e-05	0.0014	CcSEcCtD
Carmustine—Depression—Methotrexate—muscle cancer	6.44e-05	0.00139	CcSEcCtD
Carmustine—Hypotension—Etoposide—muscle cancer	6.42e-05	0.00139	CcSEcCtD
Carmustine—Muscular weakness—Doxorubicin—muscle cancer	6.4e-05	0.00138	CcSEcCtD
Carmustine—Renal failure—Methotrexate—muscle cancer	6.35e-05	0.00137	CcSEcCtD
Carmustine—Stomatitis—Methotrexate—muscle cancer	6.29e-05	0.00136	CcSEcCtD
Carmustine—Dysphagia—Doxorubicin—muscle cancer	6.27e-05	0.00136	CcSEcCtD
Carmustine—Hypersensitivity—Vincristine—muscle cancer	6.25e-05	0.00135	CcSEcCtD
Carmustine—Paraesthesia—Etoposide—muscle cancer	6.17e-05	0.00133	CcSEcCtD
Carmustine—Dyspnoea—Etoposide—muscle cancer	6.13e-05	0.00132	CcSEcCtD
Carmustine—Somnolence—Etoposide—muscle cancer	6.11e-05	0.00132	CcSEcCtD
Carmustine—Asthenia—Vincristine—muscle cancer	6.09e-05	0.00132	CcSEcCtD
Carmustine—Vomiting—Dactinomycin—muscle cancer	6.04e-05	0.00131	CcSEcCtD
Carmustine—Rash—Dactinomycin—muscle cancer	5.99e-05	0.00129	CcSEcCtD
Carmustine—Decreased appetite—Etoposide—muscle cancer	5.98e-05	0.00129	CcSEcCtD
Carmustine—Pancytopenia—Doxorubicin—muscle cancer	5.95e-05	0.00129	CcSEcCtD
Carmustine—Gastrointestinal disorder—Etoposide—muscle cancer	5.93e-05	0.00128	CcSEcCtD
Carmustine—Pain—Etoposide—muscle cancer	5.88e-05	0.00127	CcSEcCtD
Carmustine—Constipation—Etoposide—muscle cancer	5.88e-05	0.00127	CcSEcCtD
Carmustine—Neutropenia—Doxorubicin—muscle cancer	5.86e-05	0.00127	CcSEcCtD
Carmustine—Haemoglobin—Methotrexate—muscle cancer	5.82e-05	0.00126	CcSEcCtD
Carmustine—Diarrhoea—Vincristine—muscle cancer	5.81e-05	0.00126	CcSEcCtD
Carmustine—Haemorrhage—Methotrexate—muscle cancer	5.8e-05	0.00125	CcSEcCtD
Carmustine—Feeling abnormal—Etoposide—muscle cancer	5.66e-05	0.00122	CcSEcCtD
Carmustine—Hyperglycaemia—Doxorubicin—muscle cancer	5.66e-05	0.00122	CcSEcCtD
Carmustine—Nausea—Dactinomycin—muscle cancer	5.64e-05	0.00122	CcSEcCtD
Carmustine—Pneumonia—Doxorubicin—muscle cancer	5.62e-05	0.00122	CcSEcCtD
Carmustine—Gastrointestinal pain—Etoposide—muscle cancer	5.62e-05	0.00122	CcSEcCtD
Carmustine—Dizziness—Vincristine—muscle cancer	5.61e-05	0.00121	CcSEcCtD
Carmustine—Visual impairment—Methotrexate—muscle cancer	5.58e-05	0.00121	CcSEcCtD
Carmustine—Renal failure—Doxorubicin—muscle cancer	5.49e-05	0.00119	CcSEcCtD
Carmustine—Neuropathy peripheral—Doxorubicin—muscle cancer	5.48e-05	0.00118	CcSEcCtD
Carmustine—Stomatitis—Doxorubicin—muscle cancer	5.45e-05	0.00118	CcSEcCtD
Carmustine—Abdominal pain—Etoposide—muscle cancer	5.43e-05	0.00117	CcSEcCtD
Carmustine—Body temperature increased—Etoposide—muscle cancer	5.43e-05	0.00117	CcSEcCtD
Carmustine—Urinary tract infection—Doxorubicin—muscle cancer	5.43e-05	0.00117	CcSEcCtD
Carmustine—Eye disorder—Methotrexate—muscle cancer	5.42e-05	0.00117	CcSEcCtD
Carmustine—Vomiting—Vincristine—muscle cancer	5.4e-05	0.00117	CcSEcCtD
Carmustine—Rash—Vincristine—muscle cancer	5.35e-05	0.00116	CcSEcCtD
Carmustine—Dermatitis—Vincristine—muscle cancer	5.35e-05	0.00116	CcSEcCtD
Carmustine—Headache—Vincristine—muscle cancer	5.32e-05	0.00115	CcSEcCtD
Carmustine—Alopecia—Methotrexate—muscle cancer	5.12e-05	0.00111	CcSEcCtD
Carmustine—Mental disorder—Methotrexate—muscle cancer	5.08e-05	0.0011	CcSEcCtD
Carmustine—Hypersensitivity—Etoposide—muscle cancer	5.06e-05	0.00109	CcSEcCtD
Carmustine—Malnutrition—Methotrexate—muscle cancer	5.04e-05	0.00109	CcSEcCtD
Carmustine—Erythema—Methotrexate—muscle cancer	5.04e-05	0.00109	CcSEcCtD
Carmustine—Haemoglobin—Doxorubicin—muscle cancer	5.04e-05	0.00109	CcSEcCtD
Carmustine—Nausea—Vincristine—muscle cancer	5.04e-05	0.00109	CcSEcCtD
Carmustine—Haemorrhage—Doxorubicin—muscle cancer	5.02e-05	0.00108	CcSEcCtD
Carmustine—Hypoaesthesia—Doxorubicin—muscle cancer	4.99e-05	0.00108	CcSEcCtD
Carmustine—Oedema peripheral—Doxorubicin—muscle cancer	4.94e-05	0.00107	CcSEcCtD
Carmustine—Asthenia—Etoposide—muscle cancer	4.93e-05	0.00107	CcSEcCtD
Carmustine—Connective tissue disorder—Doxorubicin—muscle cancer	4.93e-05	0.00107	CcSEcCtD
Carmustine—Back pain—Methotrexate—muscle cancer	4.88e-05	0.00105	CcSEcCtD
Carmustine—Visual impairment—Doxorubicin—muscle cancer	4.84e-05	0.00105	CcSEcCtD
Carmustine—Vision blurred—Methotrexate—muscle cancer	4.75e-05	0.00103	CcSEcCtD
Carmustine—Diarrhoea—Etoposide—muscle cancer	4.7e-05	0.00102	CcSEcCtD
Carmustine—Eye disorder—Doxorubicin—muscle cancer	4.69e-05	0.00101	CcSEcCtD
Carmustine—Anaemia—Methotrexate—muscle cancer	4.66e-05	0.00101	CcSEcCtD
Carmustine—Flushing—Doxorubicin—muscle cancer	4.66e-05	0.00101	CcSEcCtD
Carmustine—Dizziness—Etoposide—muscle cancer	4.55e-05	0.000983	CcSEcCtD
Carmustine—Leukopenia—Methotrexate—muscle cancer	4.52e-05	0.000976	CcSEcCtD
Carmustine—Arrhythmia—Doxorubicin—muscle cancer	4.48e-05	0.000969	CcSEcCtD
Carmustine—Alopecia—Doxorubicin—muscle cancer	4.43e-05	0.000959	CcSEcCtD
Carmustine—Mental disorder—Doxorubicin—muscle cancer	4.4e-05	0.00095	CcSEcCtD
Carmustine—Convulsion—Methotrexate—muscle cancer	4.37e-05	0.000945	CcSEcCtD
Carmustine—Vomiting—Etoposide—muscle cancer	4.37e-05	0.000945	CcSEcCtD
Carmustine—Malnutrition—Doxorubicin—muscle cancer	4.37e-05	0.000944	CcSEcCtD
Carmustine—Erythema—Doxorubicin—muscle cancer	4.37e-05	0.000944	CcSEcCtD
Carmustine—Rash—Etoposide—muscle cancer	4.33e-05	0.000937	CcSEcCtD
Carmustine—Dermatitis—Etoposide—muscle cancer	4.33e-05	0.000936	CcSEcCtD
Carmustine—Headache—Etoposide—muscle cancer	4.31e-05	0.000931	CcSEcCtD
Carmustine—Myalgia—Methotrexate—muscle cancer	4.3e-05	0.000928	CcSEcCtD
Carmustine—Chest pain—Methotrexate—muscle cancer	4.3e-05	0.000928	CcSEcCtD
Carmustine—Back pain—Doxorubicin—muscle cancer	4.23e-05	0.000913	CcSEcCtD
Carmustine—Confusional state—Methotrexate—muscle cancer	4.15e-05	0.000897	CcSEcCtD
Carmustine—Vision blurred—Doxorubicin—muscle cancer	4.12e-05	0.00089	CcSEcCtD
Carmustine—Infection—Methotrexate—muscle cancer	4.09e-05	0.000884	CcSEcCtD
Carmustine—Nausea—Etoposide—muscle cancer	4.08e-05	0.000883	CcSEcCtD
Carmustine—Anaemia—Doxorubicin—muscle cancer	4.04e-05	0.000873	CcSEcCtD
Carmustine—Thrombocytopenia—Methotrexate—muscle cancer	4.03e-05	0.000871	CcSEcCtD
Carmustine—Agitation—Doxorubicin—muscle cancer	4.01e-05	0.000868	CcSEcCtD
Carmustine—Anorexia—Methotrexate—muscle cancer	3.92e-05	0.000848	CcSEcCtD
Carmustine—Leukopenia—Doxorubicin—muscle cancer	3.91e-05	0.000845	CcSEcCtD
Carmustine—Hypotension—Methotrexate—muscle cancer	3.85e-05	0.000832	CcSEcCtD
Carmustine—Convulsion—Doxorubicin—muscle cancer	3.78e-05	0.000818	CcSEcCtD
Carmustine—Hypertension—Doxorubicin—muscle cancer	3.77e-05	0.000815	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Methotrexate—muscle cancer	3.75e-05	0.000811	CcSEcCtD
Carmustine—Insomnia—Methotrexate—muscle cancer	3.72e-05	0.000805	CcSEcCtD
Carmustine—Myalgia—Doxorubicin—muscle cancer	3.72e-05	0.000804	CcSEcCtD
Carmustine—Chest pain—Doxorubicin—muscle cancer	3.72e-05	0.000804	CcSEcCtD
Carmustine—Anxiety—Doxorubicin—muscle cancer	3.71e-05	0.000801	CcSEcCtD
Carmustine—Paraesthesia—Methotrexate—muscle cancer	3.7e-05	0.000799	CcSEcCtD
Carmustine—Dyspnoea—Methotrexate—muscle cancer	3.67e-05	0.000793	CcSEcCtD
Carmustine—Somnolence—Methotrexate—muscle cancer	3.66e-05	0.000791	CcSEcCtD
Carmustine—Confusional state—Doxorubicin—muscle cancer	3.59e-05	0.000777	CcSEcCtD
Carmustine—Decreased appetite—Methotrexate—muscle cancer	3.58e-05	0.000774	CcSEcCtD
Carmustine—Oedema—Doxorubicin—muscle cancer	3.57e-05	0.000771	CcSEcCtD
Carmustine—Gastrointestinal disorder—Methotrexate—muscle cancer	3.55e-05	0.000768	CcSEcCtD
Carmustine—Infection—Doxorubicin—muscle cancer	3.54e-05	0.000766	CcSEcCtD
Carmustine—Pain—Methotrexate—muscle cancer	3.52e-05	0.000761	CcSEcCtD
Carmustine—Thrombocytopenia—Doxorubicin—muscle cancer	3.49e-05	0.000755	CcSEcCtD
Carmustine—Tachycardia—Doxorubicin—muscle cancer	3.48e-05	0.000752	CcSEcCtD
Carmustine—Anorexia—Doxorubicin—muscle cancer	3.4e-05	0.000735	CcSEcCtD
Carmustine—Feeling abnormal—Methotrexate—muscle cancer	3.39e-05	0.000733	CcSEcCtD
Carmustine—Gastrointestinal pain—Methotrexate—muscle cancer	3.37e-05	0.000728	CcSEcCtD
Carmustine—Hypotension—Doxorubicin—muscle cancer	3.33e-05	0.00072	CcSEcCtD
Carmustine—Abdominal pain—Methotrexate—muscle cancer	3.25e-05	0.000704	CcSEcCtD
Carmustine—Body temperature increased—Methotrexate—muscle cancer	3.25e-05	0.000704	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Doxorubicin—muscle cancer	3.25e-05	0.000702	CcSEcCtD
Carmustine—Insomnia—Doxorubicin—muscle cancer	3.22e-05	0.000697	CcSEcCtD
Carmustine—Paraesthesia—Doxorubicin—muscle cancer	3.2e-05	0.000692	CcSEcCtD
Carmustine—Dyspnoea—Doxorubicin—muscle cancer	3.18e-05	0.000687	CcSEcCtD
Carmustine—Somnolence—Doxorubicin—muscle cancer	3.17e-05	0.000685	CcSEcCtD
Carmustine—Decreased appetite—Doxorubicin—muscle cancer	3.1e-05	0.00067	CcSEcCtD
Carmustine—Gastrointestinal disorder—Doxorubicin—muscle cancer	3.08e-05	0.000665	CcSEcCtD
Carmustine—Constipation—Doxorubicin—muscle cancer	3.05e-05	0.000659	CcSEcCtD
Carmustine—Pain—Doxorubicin—muscle cancer	3.05e-05	0.000659	CcSEcCtD
Carmustine—Hypersensitivity—Methotrexate—muscle cancer	3.03e-05	0.000656	CcSEcCtD
Carmustine—Asthenia—Methotrexate—muscle cancer	2.95e-05	0.000639	CcSEcCtD
Carmustine—Feeling abnormal—Doxorubicin—muscle cancer	2.94e-05	0.000635	CcSEcCtD
Carmustine—Gastrointestinal pain—Doxorubicin—muscle cancer	2.92e-05	0.00063	CcSEcCtD
Carmustine—Body temperature increased—Doxorubicin—muscle cancer	2.82e-05	0.000609	CcSEcCtD
Carmustine—Abdominal pain—Doxorubicin—muscle cancer	2.82e-05	0.000609	CcSEcCtD
Carmustine—Diarrhoea—Methotrexate—muscle cancer	2.82e-05	0.000609	CcSEcCtD
Carmustine—Dizziness—Methotrexate—muscle cancer	2.72e-05	0.000589	CcSEcCtD
Carmustine—Hypersensitivity—Doxorubicin—muscle cancer	2.63e-05	0.000568	CcSEcCtD
Carmustine—Vomiting—Methotrexate—muscle cancer	2.62e-05	0.000566	CcSEcCtD
Carmustine—Rash—Methotrexate—muscle cancer	2.6e-05	0.000561	CcSEcCtD
Carmustine—Dermatitis—Methotrexate—muscle cancer	2.59e-05	0.000561	CcSEcCtD
Carmustine—Headache—Methotrexate—muscle cancer	2.58e-05	0.000558	CcSEcCtD
Carmustine—Asthenia—Doxorubicin—muscle cancer	2.56e-05	0.000553	CcSEcCtD
Carmustine—Nausea—Methotrexate—muscle cancer	2.45e-05	0.000529	CcSEcCtD
Carmustine—Diarrhoea—Doxorubicin—muscle cancer	2.44e-05	0.000527	CcSEcCtD
Carmustine—Dizziness—Doxorubicin—muscle cancer	2.36e-05	0.00051	CcSEcCtD
Carmustine—Vomiting—Doxorubicin—muscle cancer	2.27e-05	0.00049	CcSEcCtD
Carmustine—Rash—Doxorubicin—muscle cancer	2.25e-05	0.000486	CcSEcCtD
Carmustine—Dermatitis—Doxorubicin—muscle cancer	2.25e-05	0.000485	CcSEcCtD
Carmustine—Headache—Doxorubicin—muscle cancer	2.23e-05	0.000483	CcSEcCtD
Carmustine—Nausea—Doxorubicin—muscle cancer	2.12e-05	0.000458	CcSEcCtD
